Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.4369
H.R.4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced July 6, 2021
- Latest Major Action Oct. 20, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Versions
- Referred in Senate - Oct. 20, 2021
- Engrossed in House - Oct. 19, 2021
- Reported in House - Oct. 19, 2021
- Introduced in House - July 6, 2021
Bill Summary
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Oct. 20, 2021 |
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
Oct. 19, 2021 |
The title of the measure was amended. Agreed to without objection.
|
Oct. 19, 2021 |
Motion to reconsider laid on the table Agreed to without objection.
|
Oct. 19, 2021 |
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318). (text: CR H5645-5647)
|
Oct. 19, 2021 |
Considered as unfinished business. (consideration: CR H5662-5663)
|
Oct. 19, 2021 |
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
|
Oct. 19, 2021 |
DEBATE - The House proceeded with forty minutes of debate on H.R. 4369.
|
Oct. 19, 2021 |
Considered under suspension of the rules. (consideration: CR H5645-5647)
|
Oct. 19, 2021 |
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
|
Oct. 19, 2021 |
Placed on the Union Calendar, Calendar No. 111.
|
Oct. 19, 2021 |
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.
|
July 21, 2021 |
Ordered to be Reported (Amended) by Voice Vote.
|
July 21, 2021 |
Committee Consideration and Mark-up Session Held.
|
July 15, 2021 |
Committee Consideration and Mark-up Session Held.
|
July 15, 2021 |
Subcommittee Consideration and Mark-up Session Held.
|
July 15, 2021 |
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
|
July 7, 2021 |
Referred to the Subcommittee on Health.
|
July 6, 2021 |
Referred to the House Committee on Energy and Commerce.
|
July 6, 2021 |
Introduced in the House by Frank Pallone (D-N.J.) |